Literature DB >> 16098466

Genetic evidence for a tumor suppressor role of HIF-2alpha.

Till Acker1, Antonio Diez-Juan, Julian Aragones, Marc Tjwa, Koen Brusselmans, Lieve Moons, Dai Fukumura, Maria Paz Moreno-Murciano, Jean-Marc Herbert, Angelika Burger, Johanna Riedel, Gerd Elvert, Ingo Flamme, Patrick H Maxwell, Désiré Collen, Mieke Dewerchin, Rakesh K Jain, Karl H Plate, Peter Carmeliet.   

Abstract

The hypoxia-inducible transcription factors HIF-1alpha and HIF-2alpha are activated in hypoxic tumor regions. However, their role in tumorigenesis remains controversial, as tumor growth promoter and suppressor activities have been ascribed to HIF-1alpha, while the role of HIF-2alpha remains largely unknown. Here, we show that overexpression of HIF-2alpha in rat glioma tumors enhances angiogenesis but reduces growth of these tumors, in part by increasing tumor cell apoptosis. Moreover, siRNA knockdown of HIF-2alpha reduced apoptosis in hypoxic human malignant glioblastoma cells. Furthermore, inhibition of HIF by overexpression of a dominant-negative HIF transgene in glioma cells or HIF-2alpha deficiency in teratomas reduced vascularization but accelerated growth of these tumor types. These findings urge careful consideration of using HIF inhibitors as cancer therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16098466     DOI: 10.1016/j.ccr.2005.07.003

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  74 in total

1.  Prolyl hydroxylase PHD3 activates oxygen-dependent protein aggregation.

Authors:  Krista Rantanen; Juha Pursiheimo; Heidi Högel; Virpi Himanen; Eric Metzen; Panu M Jaakkola
Journal:  Mol Biol Cell       Date:  2008-03-12       Impact factor: 4.138

Review 2.  Role of AHR and HIF-1α in Glioblastoma Metabolism.

Authors:  Galina Gabriely; Michael A Wheeler; Maisa C Takenaka; Francisco J Quintana
Journal:  Trends Endocrinol Metab       Date:  2017-03-16       Impact factor: 12.015

3.  Hypoxia-inducible factor 1α expression is a prognostic biomarker in patients with astrocytic tumors associated with necrosis on MR image.

Authors:  Ryota Mashiko; Shingo Takano; Eiichi Ishikawa; Tetsuya Yamamoto; Kei Nakai; Akira Matsumura
Journal:  J Neurooncol       Date:  2010-07-02       Impact factor: 4.130

4.  HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers.

Authors:  Yoshifumi Baba; Katsuhiko Nosho; Kaori Shima; Natsumi Irahara; Andrew T Chan; Jeffrey A Meyerhardt; Daniel C Chung; Edward L Giovannucci; Charles S Fuchs; Shuji Ogino
Journal:  Am J Pathol       Date:  2010-04-02       Impact factor: 4.307

5.  Heterozygosity for hypoxia inducible factor 1alpha decreases the incidence of thymic lymphomas in a p53 mutant mouse model.

Authors:  Jessica A Bertout; Shetal A Patel; Benjamin H Fryer; Amy C Durham; Kelly L Covello; Kenneth P Olive; Michael H Goldschmidt; M Celeste Simon
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

6.  Differential regulation of pulmonary vascular cell growth by hypoxia-inducible transcription factor-1α and hypoxia-inducible transcription factor-2α.

Authors:  Aftab Ahmad; Shama Ahmad; Kenneth C Malcolm; Stacy M Miller; Tara Hendry-Hofer; Jerome B Schaack; Carl W White
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

7.  Human cancers converge at the HIF-2alpha oncogenic axis.

Authors:  Aleksandra Franovic; Chet E Holterman; Josianne Payette; Stephen Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-02       Impact factor: 11.205

8.  In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas.

Authors:  Rodrigo A Toledo; Yuejuan Qin; Subramanya Srikantan; Nicole Paes Morales; Qun Li; Yilun Deng; Sang-Woo Kim; Maria Adelaide A Pereira; Sergio P A Toledo; Xiaoping Su; Ricardo C T Aguiar; Patricia L M Dahia
Journal:  Endocr Relat Cancer       Date:  2013-05-21       Impact factor: 5.678

9.  Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres.

Authors:  Olga Méndez; Jiri Zavadil; Mine Esencay; Yevgeniy Lukyanov; Daniel Santovasi; Shu-Chi Wang; Elizabeth W Newcomb; David Zagzag
Journal:  Mol Cancer       Date:  2010-06-01       Impact factor: 27.401

Review 10.  PHD2 in tumour angiogenesis.

Authors:  D A Chan; A J Giaccia
Journal:  Br J Cancer       Date:  2010-05-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.